<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00775099</url>
  </required_header>
  <id_info>
    <org_study_id>05/S1103/46</org_study_id>
    <nct_id>NCT00775099</nct_id>
  </id_info>
  <brief_title>Combustion Derived Air Pollution and Vascular Function</brief_title>
  <official_title>The Effects of Combustion-Derived Air Pollution on Vascular Vasomotor and Fibrinolytic Function in Healthy Volunteers (Diesel Exposure)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Public Health and the Environment (RIVM)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Air pollution is a major cause of cardiovascular morbidity and mortality. The components of
      air pollution responsible and the mechanisms through which they might mediate these harmful
      effects remain only partially understood. The link between cardiovascular disease and air
      pollution is strongest for fine particulate matter. Fine particulate matter (PM) is produced
      from the combustion of fossil fuels with the most significant threat thought to be posed by
      small particles less than 10µm (PM 10) which can be inhaled into the lungs. We propose to
      identify the precise component of diesel exhaust that mediates the adverse cardiovascular
      effects using a carbon particle generator, and a particle concentrator. The aim of this study
      proposal is to assess the vascular effects of different types and components of air pollution
      in healthy subjects. We intend to test the hypotheses that:

        1. Combustion derived nanoparticulate causes an acute impairment of endothelial vasomotor
           and fibrinolytic function in healthy volunteers.

        2. Exposure to combustion derived air pollution is associated with increased thrombus
           formation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <primary_completion_date type="Actual">March 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forearm blood flow measured by forearm venous occlusion plethysmography in response to infused vasodilators</measure>
    <time_frame>6-8 hours after exposure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ex-vivo thrombus formation assessed using the Badimon chamber</measure>
    <time_frame>6 hours after exposure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial stiffness measured by radial artery tonometry</measure>
    <time_frame>Before and after exposure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate and heart rate variability measured with 3 lead Holter electrographic monitors</measure>
    <time_frame>During and for 24 hours after exposure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>During and after exposure and during forearm study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma t-PA and PAI concentrations following infusion of bradykinin</measure>
    <time_frame>During forearm study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma inflammatory markers IL-6, TNF-alpha, IL-1 and hsCRP</measure>
    <time_frame>Before and after exposure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet monocyte binding as measured by flow cytometry</measure>
    <time_frame>After the exposure</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>Filtered Air Exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to filtered air during intermittent exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diesel Exhaust Exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to dilute diesel exhaust at a concentration of 300 µg/m3 during intermittent exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Filtered Diesel Exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to diesel exhaust with all particulates filtered out using teflon filter with intermittent exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PALAS Exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to pure carbon particles produced by PALAS generator during intermittent exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Forearm Vascular Study</intervention_name>
    <description>Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 mg/min).</description>
    <arm_group_label>Filtered Air Exposure</arm_group_label>
    <arm_group_label>Diesel Exhaust Exposure</arm_group_label>
    <arm_group_label>Filtered Diesel Exposure</arm_group_label>
    <arm_group_label>PALAS Exposure</arm_group_label>
    <other_name>BK</other_name>
    <other_name>SNP</other_name>
    <other_name>ACh</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Badimon Chamber</intervention_name>
    <description>Ex-vivo assessment of thrombus formation using Badimon Chamber</description>
    <arm_group_label>Filtered Air Exposure</arm_group_label>
    <arm_group_label>Diesel Exhaust Exposure</arm_group_label>
    <arm_group_label>Filtered Diesel Exposure</arm_group_label>
    <arm_group_label>PALAS Exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

        Exclusion Criteria:

          -  Current smokers

          -  Significant occupational exposure to air pollution

          -  History of lung disease

          -  Women of child-bearing potential

          -  Malignant arrhythmias

          -  Renal or hepatic failure

          -  Significant co-morbidity

          -  Systolic blood pressure &gt;190 or &lt;100 mmHg

          -  Previous history of blood dyscrasia

          -  Unable to tolerate the supine position

          -  Lack of informed consent

          -  Blood donation within last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicholas L Mills, MB BCh MRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Edinburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Mills NL, Törnqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005 Dec 20;112(25):3930-6.</citation>
    <PMID>16365212</PMID>
  </reference>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2008</study_first_submitted>
  <study_first_submitted_qc>October 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2008</study_first_posted>
  <last_update_submitted>October 16, 2008</last_update_submitted>
  <last_update_submitted_qc>October 16, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 17, 2008</last_update_posted>
  <responsible_party>
    <name_title>Professor David E Newby</name_title>
    <organization>University of Edinburgh</organization>
  </responsible_party>
  <keyword>Air Pollution</keyword>
  <keyword>Particles</keyword>
  <keyword>Particulate Matter</keyword>
  <keyword>Vascular function</keyword>
  <keyword>Endothelial function</keyword>
  <keyword>Thrombosis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

